Physician profile
Wayne Lee
NPI 1598833543
$7,059.84
in general payments reported to CMS, 2019-2025
12 companies · $361 in 2025
The $361 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $222 · 2020: $2,562 · 2021: $259 · 2022: $1,217 · 2023: $1,774 · 2024: $665 · 2025: $361.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,957 · Travel and Lodging: $843.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,957.33 |
| Travel and Lodging | $842.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,310.00 | 2023-2025 | |
| Allergan, INC. | $1,608.18 | 2019-2022 | |
| Acelrx Pharmaceuticals, INC. | $1,349.15 | 2020-2021 | |
| Acell, INC. | $1,052.00 | 2020 | |
| Smith+Nephew, INC. | $225.48 | 2019-2025 | Pico 14, Pico |
| Tela Bio, INC. | $187.52 | 2024-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Baxter Healthcare | $124.15 | 2024 | Artiss |
| Mentor Worldwide LLC | $81.01 | 2022-2023 | Mentor Memorygel Resterilizable Gel Sizer |
| Vertical Pharmaceuticals, LLC | $57.99 | 2023-2024 | Dsuvia |
| Mimedx Group, INC. | $32.53 | 2024-2025 | |
| Kci USA, INC. | $16.12 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $15.71 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wayne Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.